Although GLP-1 drugs make headlines for vision risks, other weight-loss medications carry their own eye-related side effects.

Reference numbers are in parentheses. FAS = fatty acid synthase; IL = interleukin. Increased vascular permeability, capillary nonperfusion Symptoms: decreased central acuity; signs:retinal ...

Ophthalmic Research, Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio 44195, United States Department of Ophthalmology, Cleveland Clinic Lerner College of Medicine of Case Western Reserve ...

“It turns out I had something called a drug-induced liver injury, which came from my supplements.” The liver is responsible for more than 500 functions in the human body, including filtering ...

Kidney transplant recipients with type 2 diabetes treated with a new class of anti-obesity drugs were less likely ... promise for detecting diabetic retinopathy, few patients are given AI-assisted ...

Perspective from David A. Eichenbaum, MD The FDA approved Susvimo 100 mg/mL to treat diabetic retinopathy, according to a press release from Genentech. The approval was supported by positive 1 ...

plus tiered royalties on future products The expanded collaboration aims to push the boundaries of induced proximity drug discovery by pursuing targets and mechanisms that have historically been ...

Susvimo can help people with diabetic retinopathy (DR) maintain their vision and prevent progression to blindness with only one treatment every nine months – – Susvimo’s innovative ...

Continuing high prices and demand for GLP-1 weight-loss drugs is creating lots of questions about the affordability of these drugs for U.S. healthcare consumers. For more than two years ...

Learn which drugs can cause dry eye disease, and what to do if you’re taking a medication that can cause dry eye symptoms.